Variant report
Variant | esv3384378 |
---|---|
Chromosome Location | chr6:66607280-66635054 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148278228 | chr6:66609852-66609853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369602340 | chr6:66609895-66609896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532347112 | chr6:66609909-66609910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561043301 | chr6:66609964-66609965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575480875 | chr6:66609976-66609977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529716026 | chr6:66609982-66609983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549460819 | chr6:66609989-66609990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1353874 | chr6:66609996-66609997 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs9453479 | chr6:66610017-66610018 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs552066074 | chr6:66610021-66610022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141306891 | chr6:66610027-66610028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1353873 | chr6:66610049-66610050 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs183066608 | chr6:66610069-66610070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1353872 | chr6:66610076-66610077 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs537590812 | chr6:66610219-66610220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9363483 | chr6:66610269-66610270 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs577345687 | chr6:66610314-66610315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539811959 | chr6:66610315-66610316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544182733 | chr6:66610347-66610348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553653729 | chr6:66610394-66610395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150796080 | chr6:66610400-66610401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556965026 | chr6:66622653-66622654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576754935 | chr6:66622751-66622752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9453501 | chr6:66622815-66622816 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs553257249 | chr6:66622830-66622831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573094883 | chr6:66622868-66622869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542011410 | chr6:66622880-66622881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs5876993 | chr6:66622906-66622907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs397937940 | chr6:66622909-66622910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71268352 | chr6:66622910-66622911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34103153 | chr6:66622920-66622921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1938094 | chr6:66622921-66622922 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs147325615 | chr6:66622952-66622953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564543984 | chr6:66622953-66622954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12214948 | chr6:66633603-66633604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs552651970 | chr6:66633618-66633619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186363092 | chr6:66633668-66633669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528791504 | chr6:66633671-66633672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs80188754 | chr6:66633675-66633676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568661935 | chr6:66633687-66633688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373637757 | chr6:66633723-66633724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188788639 | chr6:66633759-66633760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6939062 | chr6:66633781-66633782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs569438406 | chr6:66633804-66633805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371562586 | chr6:66633910-66633911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6927036 | chr6:66633911-66633912 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs558000742 | chr6:66633916-66633917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558561205 | chr6:66633917-66633918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544160563 | chr6:66633918-66633919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571903520 | chr6:66633933-66633934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66609800-66610400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr6:66622600-66623000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:66633600-66634000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:66633600-66634000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr6:66634000-66634400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr6:66634000-66634800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr6:66634400-66636000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr6:66634800-66635000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr6:66635000-66635400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |